Latest Earnings Results: Q2 '26
Estimated EPS
-$0.72
Reported EPS
-$0.80
Surprise
-11.63%
Estimated Rev
$28.97M
Reported Rev
$31.64M
Surprise
+9.21%
• Reported GAAP EPS of -$0.97 up 6.73% YoY • Reported revenue of $31.64M up 0.69% YoY • Outset Medical reiterated its 2026 revenue guidance of $125 million to $130 million, representing a 5% to 9% increase over 2025, and expects non-GAAP gross margin in the low-40% to mid-40% range.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.69 | -- | -- | N/A |
Q2 '26 | -$0.72 | -$0.80 | -11.63% | MISSED |
Q1 '26 | -$0.79 | -$0.83 | -5.06% | MISSED |
Q4 '25 | -$0.67 | -$0.84 | -24.65% | MISSED |
Q3 '25 | -$0.65 | -$0.69 | -5.34% | MISSED |